Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
To compare the short and long term effects of inhibitor of the DPP-IV enzyme, sitagliptin ,
with bedtime NPH insulin in patients with T2D inadequately controlled with sulphonylurea plus
biguanide: effects on beta cell function and on metabolic profile.
Phase:
Phase 4
Details
Lead Sponsor:
University of Sao Paulo General Hospital
Collaborator:
Fundação de Amparo à Pesquisa do Estado de São Paulo